LUCENTIS (RANIBIZUMAB) — FDA Approval BLA125156 (GENENTECH)
LUCENTIS (RANIBIZUMAB) — FDA Approval BLA125156 (GENENTECH) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LUCENTIS; Active ingredients: RANIBIZUMAB; Application number: BLA125156.
| Brand name | LUCENTIS |
|---|---|
| Active ingredients | RANIBIZUMAB |
| Application number | BLA125156 |
| Sponsor | GENENTECH |
| Dosage form | Injectable |
| Route | Injection |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20060630 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →